# Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes

> **NCT03797534** · NA · UNKNOWN · sponsor: **Fujian Medical University** · enrollment: 600 (estimated)

## Conditions studied

- Heart Valve Prosthesis

## Interventions

- **OTHER:** dose regime

## Key facts

- **NCT ID:** NCT03797534
- **Lead sponsor:** Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2019-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03797534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03797534, "Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03797534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*